search
Back to results

Metal Ion Concentration Between Coated and Uncoated TKA

Primary Purpose

Knee Osteoarthritis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Coated Total Knee Arthroplasty
Standard Total Knee Arthroplasty
Sponsored by
Technische Universität Dresden
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Total Knee Arthroplasty, Total Knee Replacement, Outcome, Metal ion concentration, Results

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • indication to TKA
  • no other metal implant

Exclusion Criteria:

  • no informed consent
  • not able to understand study and/or questionnaires
  • Need of a higher constrained implant

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Coated Total Knee Arthroplasty

    Standard Total Knee Arthroplasty

    Arm Description

    Implantation of a coated Total Knee Arthroplasty

    Implantation of a Standard Total Knee Arthroplasty

    Outcomes

    Primary Outcome Measures

    Metal Ions (Cobalt, Chromium, Molydenum, Nickel)
    Change in Serum Metal Ion concentrations 1 and 5 years after surgery

    Secondary Outcome Measures

    Function
    Knee Society Score
    Patient Reported Outcome
    Oxford Knee Score
    Health-related Quality of Life
    SF 36
    Activity
    UCLA activity score

    Full Information

    First Posted
    January 24, 2017
    Last Updated
    January 28, 2020
    Sponsor
    Technische Universität Dresden
    Collaborators
    Mathys Ltd Bettlach
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03047564
    Brief Title
    Metal Ion Concentration Between Coated and Uncoated TKA
    Official Title
    Metal Ion Concentration and Clinical Outcome Between Coated and Uncoated TKA
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2020
    Overall Recruitment Status
    Unknown status
    Study Start Date
    February 1, 2012 (Actual)
    Primary Completion Date
    February 28, 2015 (Actual)
    Study Completion Date
    December 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Technische Universität Dresden
    Collaborators
    Mathys Ltd Bettlach

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Metal ion release from metal implants may have side effects. It can be reduced by coating of the implant. This study compares coated and uncoated TKA.
    Detailed Description
    Patients are randomized to receive a coated or uncoated TKA. Patients are assessed before surgery, after 3 month, 1 year and 5 years. Blood samples are collected in 7.5 ml S-Monovette® tubes (for trace metal analysis, Sarstedt AG, Germany) using a specific steel needle for trace metal analysis (Sarstedt AG, Germany). Within one hour, plasma was separated by centrifugation at 2500g for ten minutes. Samples were stored at -20°C before being analysed for chromium, cobalt, molybdenum and nickel content using a graphite furnace atomic absorption spectrometer Z-8270 with Polarisation-Zeeman-Absorption (Hitachi Ltd., Japan). The accuracy and precision of the method is validated to < 10% using the control materials SeronormTM Trace Elements Serum (SERO AS, Norway). The detection limit of the method is estimated at 0.5µg/l for chromium, cobalt and molybdenum, 1.0µg/l for nickel (mean + 3 standard deviations from buffer). All probes having ion levels below the detection limit were adjusted to 0.25µg/l for chromium, cobalt and molybdenum and 0.5µg/l for nickel. Clinical outcome is measured with the Knee Society Score, Oxford Knee Score, Short-Form 36 and University of Los Angeles Activity Score.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Knee Osteoarthritis
    Keywords
    Total Knee Arthroplasty, Total Knee Replacement, Outcome, Metal ion concentration, Results

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomization to one of two implants
    Masking
    None (Open Label)
    Masking Description
    No masking
    Allocation
    Randomized
    Enrollment
    120 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Coated Total Knee Arthroplasty
    Arm Type
    Experimental
    Arm Description
    Implantation of a coated Total Knee Arthroplasty
    Arm Title
    Standard Total Knee Arthroplasty
    Arm Type
    Active Comparator
    Arm Description
    Implantation of a Standard Total Knee Arthroplasty
    Intervention Type
    Device
    Intervention Name(s)
    Coated Total Knee Arthroplasty
    Intervention Description
    Implantation of a coated Total Knee Arthroplasty
    Intervention Type
    Device
    Intervention Name(s)
    Standard Total Knee Arthroplasty
    Intervention Description
    Implantation of a Standard Total Knee Arthroplasty
    Primary Outcome Measure Information:
    Title
    Metal Ions (Cobalt, Chromium, Molydenum, Nickel)
    Description
    Change in Serum Metal Ion concentrations 1 and 5 years after surgery
    Time Frame
    before surgery, 1 year, 5 years
    Secondary Outcome Measure Information:
    Title
    Function
    Description
    Knee Society Score
    Time Frame
    before surgery, 3 month, 1 year, 5 years
    Title
    Patient Reported Outcome
    Description
    Oxford Knee Score
    Time Frame
    before surgery, 3 month, 1 year, 5 years
    Title
    Health-related Quality of Life
    Description
    SF 36
    Time Frame
    before surgery, 3 month, 1 year, 5 years
    Title
    Activity
    Description
    UCLA activity score
    Time Frame
    before surgery, 3 month, 1 year, 5 years
    Other Pre-specified Outcome Measures:
    Title
    Adverse Events
    Description
    Adverse Events
    Time Frame
    through study completion, in average 5 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: indication to TKA no other metal implant Exclusion Criteria: no informed consent not able to understand study and/or questionnaires Need of a higher constrained implant
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jörg Lützner, MD
    Organizational Affiliation
    University Hospital Carl Gustav Carus
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Metal Ion Concentration Between Coated and Uncoated TKA

    We'll reach out to this number within 24 hrs